Category

Drug Development Pharma

FDA approved

FDA approval for Genmab’s Darzalex in combination with Bortezomib, Thalidomide and Dexamethasone

October 2, 2019

Genmab has announced that the …

Emmanuel Dulac

Zealand Pharma and Boehringer Ingelheim initiate Phase 2 development of BI 456906

September 4, 2019

Boehringer Ingelheim plans to initiate …

Mene Pangalos

FDA grants Fast Track designation for AstraZeneca’s Farxiga

August 28, 2019

The US Food and Drug …

FDA approved

FDA approves Orion’s and Bayer’s darolutamide

August 1, 2019

The approval of darolutamide is …

Xbrane team

Xbrane enters term-sheet with STADA

June 4, 2019

The company has entered a …

Carl-Johan Dalsgaard

Vicore Pharma announces second indication for VP01

April 23, 2019

The company has selected diffuse …

Follicum selects new drug candidate

February 11, 2019

The biotech company reports that …

Nordic Nanovector

Nordic Nanovector has been granted Fast Track designation

June 12, 2018

The US Food & Drug …

Lundbeck research

Lundbeck expands clinical pipeline and divests preclinical research programs

May 22, 2018

The company starts the clinical …

Christian Målov Novo Nordisk

Novo Nordisk increases its focus on stem cell-based therapies

May 22, 2018

The Danish pharma company has …

Maihara factory in Japan

Regulatory submission in Japan for AstraZeneca

May 21, 2018

AstraZeneca has submitted a supplemental …

Oncology antibody AstraZeneca

Biologics License Application approval for AstraZeneca

April 4, 2018

AstraZeneca and MedImmune has announced …

Philip Wood

New data from Sobi

February 8, 2018

Swedish Orphan Biovitrum will present …

bergenbio_richard_godfrey

BerGenBio shows encouranging results

January 29, 2018

BerGenBio announces the presentation of …

Sobi Research

FDA accepts Sobi’s IND application

January 23, 2018

Swedish Orphan Biovitrum announces that …

Hair loss

New receptors found for Follicum’s lead candidate

January 19, 2018

New research has identified receptors …

1
2
3
···
11